Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Factors and Outcomes Associated With Use of Cabergoline Among Postpartum Women in Israel

NCT03965572 is registered in ClinicalTrials.gov with Laniado Hospital as lead sponsor.

NCT NCT03965572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03965572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Factors and Outcomes Associated With Use of Cabergoline Among Postpartum Women in Israel
Lead sponsor
Laniado Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 7, 2019
Completion date
May 12, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cabergoline adverse reaction, lactation suppressed, postpartum depression, postpartum dvt